BLOCKCHAIN FOR CLINICAL TRIALS FORUM
Setting a New Standard for Optimizing Clinical Trials Operations
12 February 2018 – Orlando Science Center, FL
Rising drug development costs (estimated between $161MM to $2Bn) and the length of time (anywhere from 7.5 to 12 years from clinical testing to marketing) are major barriers to innovation in drug development. Pharmaceutical companies conduct clinical trials with the goal to demonstrate safety and efficacy of the medicine to get the US FDA (Food to gain Food and Drug Administration) or other regional authority’s approval. Improving the drug development process, especially by conducting better (more safely and efficient) and faster clinical trials, will accelerate innovation in healthcare.
Clinical researchers are facing many changes in today’s complex, heavily-regulated, data-sharing economy. Existing legacy platforms cannot effectively manage the two competing needs of data sharing and patient privacy while ensuring data integrity. The lack of verifiable, secure, and transparent platform to effectively distribute data to trusted partners is a direct impact on advancing innovation in patient care, patient safety and healthcare.